Tradition Wealth Management’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-167
Closed -$3K 1229
2022
Q3
$3K Buy
+167
New +$1.94K ﹤0.01% 1177
2021
Q3
Sell
-4,092
Closed -$66K 1231
2021
Q2
$66K Buy
+4,092
New +$70.2K 0.01% 472

Tradition Wealth Management's AERI Position: Q4 2022 in Review

Tradition Wealth Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 167 shares — an estimated $3K sold.

Tradition Wealth Management first reported a position in AERI in Q2 2021 and held it in 2 quarters. The position peaked at $66K in Q2 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Tradition Wealth Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Tradition Wealth Management sold 167 Aerie Pharmaceuticals shares in Q4 2022, an estimated $3K.
  • Tradition Wealth Management first reported a position in Aerie Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Tradition Wealth Management's Aerie Pharmaceuticals position peaked at $66K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Tradition Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.